candidates for glp 1 GLP-1 medications are NOT everyone. These medications can help reduce visceral fat, improve insulin response, and support sustainable metabolic health… But they're not “quick cosmetic weight loss injections.” And In the What's next for GLP-1 innovation:

On August 28, 2024, Eli Lilly and Company submitted anominationto request that its GLP-1 product, tirzepatide, be added to FDAs Demonstrable Difficulties for Compounding (DDC) lists.

President Donald Trump signed an executive Saturday that aims to accelerate research and approval of psychedelic-based therapies for conditions such as PTSD.

Deze botanische extracten zijn rijk aan natuurlijke polyfenolen en worden ondersteund door chroom, een essentieel mineraal

Learn the truth about compounded GLP-1 medications, debunking misleading claims about safety and legitimacy and explaining how accredited pharmacy compounding fits into care.